Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: United Kingdom Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20041
20052
20062
20073
20083
20093
20102
20112
20124
20132
20142
20155
20163
20172
20192
20212
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting4
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S20
Eli Lilly and Company4
Mannkind Corporation3
AstraZeneca2
Boehringer Ingelheim2
Lexicon Pharmaceuticals2
Sanofi2
Andromeda Biotech Ltd.1
Bayer1
Chromaderm, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 151
Diabetes Mellitus23
Diabetes Mellitus, Type 27
Hypoglycemia2
Retinal Diseases2
Asthma1
Cardiovascular Diseases1
Chronic Limb-Threatening Ischemia1
Diabetic Nephropathies1
Diabetic Neuropathies1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.